1. Home
  2. PULM vs ARKR Comparison

PULM vs ARKR Comparison

Compare PULM & ARKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • ARKR
  • Stock Information
  • Founded
  • PULM 2003
  • ARKR 1983
  • Country
  • PULM United States
  • ARKR United States
  • Employees
  • PULM N/A
  • ARKR N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • ARKR Restaurants
  • Sector
  • PULM Health Care
  • ARKR Consumer Discretionary
  • Exchange
  • PULM Nasdaq
  • ARKR Nasdaq
  • Market Cap
  • PULM 33.2M
  • ARKR 32.5M
  • IPO Year
  • PULM N/A
  • ARKR N/A
  • Fundamental
  • Price
  • PULM $5.62
  • ARKR $8.62
  • Analyst Decision
  • PULM
  • ARKR
  • Analyst Count
  • PULM 0
  • ARKR 0
  • Target Price
  • PULM N/A
  • ARKR N/A
  • AVG Volume (30 Days)
  • PULM 11.2K
  • ARKR 3.1K
  • Earning Date
  • PULM 08-12-2025
  • ARKR 08-11-2025
  • Dividend Yield
  • PULM N/A
  • ARKR N/A
  • EPS Growth
  • PULM N/A
  • ARKR N/A
  • EPS
  • PULM N/A
  • ARKR N/A
  • Revenue
  • PULM $1,921,000.00
  • ARKR $178,516,000.00
  • Revenue This Year
  • PULM N/A
  • ARKR N/A
  • Revenue Next Year
  • PULM $134.88
  • ARKR N/A
  • P/E Ratio
  • PULM N/A
  • ARKR N/A
  • Revenue Growth
  • PULM N/A
  • ARKR N/A
  • 52 Week Low
  • PULM $1.78
  • ARKR $8.25
  • 52 Week High
  • PULM $10.40
  • ARKR $17.76
  • Technical
  • Relative Strength Index (RSI)
  • PULM 32.49
  • ARKR 35.21
  • Support Level
  • PULM $5.60
  • ARKR $8.66
  • Resistance Level
  • PULM $6.15
  • ARKR $9.01
  • Average True Range (ATR)
  • PULM 0.28
  • ARKR 0.25
  • MACD
  • PULM -0.05
  • ARKR 0.04
  • Stochastic Oscillator
  • PULM 1.63
  • ARKR 15.49

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About ARKR Ark Restaurants Corp.

Ark Restaurants Corp owns and operates around 17 restaurants and bars, 16 fast food concepts, and catering operations in the USA. The Las Vegas operations include New York Hotel & Casino Resort, hotel room service operations, banquet facilities, employee dining room, food court concepts, and a restaurant within the Planet Hollywood Resort and Casino. It operates a restaurant and a bar in the Resorts Atlantic City Hotel and Casino and a restaurant in the Tropicana Hotel and Casino. The Florida operations include The Rustic Inn in Dania Beach, Shuckers in Jensen Beach, JB's on the Beach in Deerfield Beach, The Blue Moon Fish Company in Fort Lauderdale, and fast food facilities in Tampa and Hollywood. In Alabama, it operates Original Oyster Houses in Gulf Shores and Spanish Fort.

Share on Social Networks: